(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: sheath: 6f terumo destination, embolic protection: emboshield nav6 6 eps.The device was not returned for analysis.A review of the lot history record revealed no non-conformance's that would have contributed to the reported event.A query of the complaint handling database revealed no other similar incidents reported from this lot.The investigation was unable to determine a cause for the reported inaccurate delivery.It may be possible that anatomical conditions contributed to the inaccurate delivery; however, this could not be confirmed.The additional treatment was due to case circumstances.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
It was reported that the procedure was performed to treat a concentric de novo lesion in the proximal internal carotid artery with 95-99% narrowing and 8-10mm of mild calcification.An emboshield nav6 embolic protection system was advanced and placed distal to the lesion.Subsequently, a non-abbott balloon dilatation catheter (bdc) was advanced to the lesion and pre-dilation was performed.A 6x20mm acculink rx self-expanding stent system was then advanced to the lesion and the stent was slowly deployed by the physician.During deployment, a distal dislocation of the stent was observed.The physician pulled at the delivery system to keep the stent in the target lesion; however, the implanted stent covered 50% of the target lesion, and the remaining portion of the stent was almost fully implanted distal to the target lesion, with narrowing at the proximal stent entry.A 5.0x20mm viatrac bdc was used to post-dilate the narrowing.Finally, a 9x7x40mm xact stent was implanted, with a 10mm overlap into the implanted acculink stent and approximately 20mm over the carotid bifurcation.There was no adverse patient sequela and no reported clinically significant delay in the procedure.No additional information was provided.
|